-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on AdaptHealth, Lowers Price Target to $14

Benzinga·05/06/2026 21:34:59
Listen to the news
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $15 to $14.